Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunityBio converts from Immunomedics -- Ignore unavailable to you. Want to Upgrade?

To: Stanley Lake 92 who wrote (847)	1/27/2025 10:59:50 PM
From: bobbseytwins2001	Read Replies (1) \| Respond to of 1232

Why, and at what price?

To: Stanley Lake 92 who wrote (847)	1/28/2025 12:54:29 AM
From: dorightbythem	Read Replies (1) \| Respond to of 1232

I realize this group doesn’t have the type of censorship as the IMMU group but for goodness sake do a little more research before posting anything from X. You may have run across the term “ Rare “ and not some click bait.

To: Stanley Lake 92 who wrote (847)	1/31/2025 3:15:33 PM
From: luckydog88	1 Recommendation Recommended By Stanley Lake 92 Read Replies (3) \| Respond to of 1232

Continuing what you pointed out, this certainly is not a good look today. yahoo.com I really dont care to discuss politics here (or anywhere to be honest), but as others have pointed out PSS is the company in this case. Like others here have said, its an added dimension when assessing the risk of holding the stock (and I do own a significant amount of shares), especially one that by most accounts seems way undervalued - so maybe the reason it is so undervalued is simply PSS?